Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Dec 5;97(25):13532-6.
doi: 10.1073/pnas.240464097.

The zalpha domain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA

Affiliations

The zalpha domain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA

B A Brown 2nd et al. Proc Natl Acad Sci U S A. .

Abstract

The Zalpha domain of human double-stranded RNA adenosine deaminase 1 binds specifically to left-handed Z-DNA and stabilizes the Z-conformation. Here we report spectroscopic and analytical results that demonstrate that Zalpha can also stabilize the left-handed Z-conformation in double-stranded RNA. Zalpha induces a slow transition from the right-handed A-conformation to the Z-form in duplex r(CG)(6), with an activation energy of 38 kcal mol(-1). We conclude that Z-RNA as well as Z-DNA can be accommodated in the tailored binding site of Zalpha. The specific binding of Z-RNA by Zalpha may be involved in targeting double-stranded RNA adenosine deaminase 1 for a role in hypermutation of RNA viruses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Z-RNA conformation can be stabilized by Zα, as shown by CD and Raman spectroscopy. CD studies: (A) Spectra are shown for 5 μM duplex r(CG)6 in the A-form (–⋅–⋅–). All samples contained 10 mM Na2HPO4 (pH 7), 20 mM NaCl, and 0.5 mM EDTA. In 6.5 M NaClO4, the typical Z-RNA spectrum is seen (– – –). The A-RNA spectrum changes as Zα is added (Zα has no CD signal above 250 nm, but a strong negative ellipticity below 250 nm). Spectra are shown for the addition of 5 μM Zα (-⋅⋅-⋅⋅-), which is 1 Zα:12 bp; 10 μM Zα (⋅ ⋅ ⋅ ⋅), 1:6; 15 μM Zα (- - - -), 1:4; and 30 μM Zα (——), 1:2. Inversion of the CD bands around 285 nm and the decrease in signal at 266 nm are characteristic of the A → Z transition. Raman spectroscopy: (B) The A-form of r(CG)6 (5 mM duplex) has doublet peaks at 784 and 814 cm−1, which are characteristic of the A-conformation. (C) Z-conformation of r(CG)6 (5 mM duplex) induced by 6.5 M NaBr. The bands at 781 and 638 cm−1 and markedly reduced intensity at 810 cm−1 distinguish the Z-RNA conformation from the A-form (B). (D) Zα⋅r(CG)6 complex containing 15 mM Zα and 5 mM r(CG)6 duplex (1 Zα:4 bp RNA). This spectrum has several features identical to those of the salt-induced Z-RNA spectrum (C), notably intensities at 638, 781, and 810 cm−1. (E) Difference spectrum created by digitally subtracting the Zα spectrum (F) from that of the Zα⋅RNA complex (D). (F) Zα peptide spectrum (15 mM Zα). Raman bands for the aromatic amino acids tryptophan and tyrosine are labeled.
Figure 2
Figure 2
Perturbation of Zα⋅r(CG)6 complex results in reversion of Z-RNA to the A-conformation, as seen in CD spectra. (A) NaCl titration of Zα⋅r(CG)6 complex (30 μM Zα, 5 μM r(CG)6 duplex; 1 Zα:2 bp RNA). As NaCl is added, the broad Z-RNA peak around 285 nm gradually decreases, and then inverts, signifying reversion to the A-conformation. Representative points shown are 0.04 M NaCl (——), 0.5 M (- - - -), 0.6 M (⋅ ⋅ ⋅ ⋅), 0.8 M (–⋅⋅–⋅⋅–), and 1 M NaCl (–⋅–⋅–). The midpoint of the titration is ca. 0.7 M NaCl. (B) Urea denaturation of Zα⋅r(CG)6 complex. The urea titration was monitored at 285 (■), 266 (○), and 230 nm (⋄), corresponding to major ellipticity signals of Z-RNA, A-RNA, and Zα protein, respectively. The relative amount of Z-RNA decreases coincident with an increase in the A-RNA signal, as Zα is denatured by increasing urea. (C) Thermal denaturation of the Zα⋅r(CG)6 complex monitored at 285 (■), 266 (○), and 222 nm (⋄), corresponding to the major signal intensities for Z-RNA, A-RNA, and Zα, respectively. As the temperature is increased, the relative amount of Z-RNA decreases as Zα begins to denature (ca. 60°C). In addition, as the Z-RNA signal decreases, the A-RNA signal increases from 60°C up to approximately 80°C, above which the RNA denatures and the ellipticity drops at 266 nm, with a slight rise at 285 nm. Individual melting experiments yielded Tm values of 69, 86, and 77°C for Zα, r(CG)6, and Zα⋅r(CG)6, respectively.
Figure 3
Figure 3
Temperature dependence of the A → Z-RNA transition. (A) Kinetics of the A → Z transition as a function of temperature. CD traces at 285 nm of the Zα-induced conformational transitions are shown for 25, 32, 37, 45, and 55°C (the 50°C trace was omitted for clarity). The kinetics for the A → Z transition are first-order and were fit to single exponentials to obtain rate constants (Table 1). (B) The rates of the A → Z transition for the r(CG)6 duplex at 45 and 50°C (285 nm) are comparable to the rate of B → Z transition of d(CG)6 (264 nm) at 25°C, demonstrating the higher-energy requirements of the A → Z transition. (C) Temperature dependence for Z-conformational transition of r(CG)6 (■) or d(CG)6 (●). Arrhenius plots constructed from rate data as a function of temperature yielded activation energies of 38.1 ± 0.5 and 24.0 ± 0.8 kcal mol−1 for r(CG)6 and d(CG)6, respectively. Correlation coefficients for the Arrhenius plots of r(CG)6 and d(CG)6 were 0.999 and 0.998, respectively.

References

    1. Higuchi M, Single F N, Kohler M, Sommer B, Sprengel R, Seeburg P H. Cell. 1993;75:1361–1370. - PubMed
    1. Herbert A, Lowenhaupt K, Spitzner J, Rich A. Proc Natl Acad Sci USA. 1995;92:7550–7554. - PMC - PubMed
    1. Schwartz T, Lowenhaupt K, Kim Y G, Li L, Brown B A, II, Herbert A, Rich A. J Biol Chem. 1999;274:2899–2906. - PubMed
    1. Herbert A, Alfken J, Kim Y G, Mian I S, Nishikura K, Rich A. Proc Natl Acad Sci USA. 1997;94:8421–8426. - PMC - PubMed
    1. Schade M, Behlke J, Lowenhaupt K, Herbert A, Rich A, Oschkinat H. FEBS Lett. 1999;458:27–31. - PubMed

Publication types